Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase 2 Study of Vapendavir in Asthmatic Adults With Symptomatic Human Rhinovirus Infection

ClinicalTrials.gov ID: NCT02367313

Public ClinicalTrials.gov record NCT02367313. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 5:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Dose-ranging Study of Vapendavir in Moderate to Severe Asthmatic Adults With Symptomatic Human Rhinovirus Infection

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 2 protocol is designed to compare two dose levels of Vapendavir versus placebo. The objectives are to obtain safety and efficacy data in moderate to severe asthmatic patients, aged 18 to 75 years at risk of loss of asthma control due to presumptive Human Rhinovirus infection.

Study identification

NCT ID
NCT02367313
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Biota Pharmaceuticals, Inc.
Industry
Enrollment
455 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2015 (Type not available)
Primary completion
Dec 2016 (Actual)
Completion
Dec 2016 (Actual)
Last update posted
Jun 1, 2018

2015 – 2016

United States locations

U.S. sites
33
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
Biota Investigational site Birmingham Alabama 35209 —
Biota Investigational site Flagstaff Arizona 86001 —
Biota Investigational site Bakersfield California 93301 —
Biota Investigational site Los Angeles California 90025 —
Biota Investigational site Orange California 92868 —
Biota Investigational Site San Jose California 95117 —
Biota Investigational site Stockton California 95207 —
Biota Investigational site Centennial Colorado 80112 —
Biota Investigational site Denver Colorado 80230 —
Biota Investigational site Hialeah Florida 33016 —
Biota Investigational site New Port Richey Florida 34653 —
Biota Investigational site Oviedo Florida 32765 —
Biota Investigation site Palmetto Bay Florida 33157 —
Biota Investigational site Tallahassee Florida 32308 —
Biota Investigational site Twin Falls Idaho 83301 —
Biota Investigational site Baltimore Maryland 21236 —
Biota Investigational site St Louis Missouri 63141 —
Biota Investigational site Bellevue Nebraska 68123 —
Biota investigational site Las Vegas Nevada 89146 —
Biota Investigational site Ocean City New Jersey 07712 —
Biota Investigational site Albuquerque New Mexico 87102 —
Biota Investigational site Rockville Centre New York 11570 —
Biota Investigational site Raleigh North Carolina 27607 —
Biota Investigational site Fargo North Dakota 58103 —
Biota Investigational site Middleburg Ohio 44310 —
Biota Investigational site Toledo Ohio 43617 —
Biota Investigation site Oklahoma City Oklahoma 73120 —
Biota Investigational site Medford Oregon 97504 —
Biota Investigational site Portland Oregon 97202 —
Biota Investigational site Warwick Rhode Island 02886 —
Biota Investigational site Houston Texas 77055 —
Biota Investigational site Seattle Washington 98115 —
Biota Investigational site Greenfield Wisconsin 53228 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02367313, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2018 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02367313 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →